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ABSTRACT 
Introduction. IgA nephropathy is the dominant primary 
glomerular disease found throughout the majority of the 
world’s developed countries. Accurately identifying patients 
who are at risk of progressive disease is challenging. We 
aimed to characterise clinical and histological features that 
predict poor prognosis in adults.
Patients and Methods. We performed a single-centre 
retrospective observational study of biopsy-proven IgA 
nephropathy. The primary outcome was renal survival and 
death from any cause, and the secondary outcome was 
proteinuria remission.
Results. Data from 49 cases were available for analysis 
with a median follow-up of 4 years. There were no deaths. 
Univariable analyses identified acute renal failure, low esti-
mated glomerular filtration rate for ≥3 months (low eGFR), 
arterial hypertension, baseline proteinuria, glomerular scle-
rosis >50% and interstitial fibrosis >50% as poor prognostic 
markers. Low eGFR persisted significant by multivariable 
model that used only clinical parameters. Multivariable models 
with histopathologic parameters observed that tubular 
 atrophy/interstitial fibrosis >50% was independently associated 
with the primary outcome. Proteinuria remission throughout 
follow-up had no prognostic value in our revision.
Conclusions. Two independent predictors of poor renal 
survival at time of biopsy were found: low eGFR and 
tubular atrophy/interstitial fibrosis >50%.
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INTRODUCTION 
IgA nephropathy (IgAN) is the most common primary glom-
erulonephritis in countries where screening for kidney disease 
and renal biopsy are widely practiced. Disease prevalence 
accounted for 17.2, 34.5, 34.9, 35.2 and 38.8% of all primary 
glomerulonephritis reported from Spain, Czech Republic, Fin-
land, Italy and Northern Ireland respectively. Conversely, IgAN 
is not commonly reported in Africans. The reported incidence 
of IgAN ranged from 2.5 to 5.8% of all primary glomerulone-
phritis in Senegal, Sudan and South Africa1. No clinical pattern 
is pathognomonic of IgAN and a large cohort of undiagnosed 
latent IgAN is present in the general population.
Although this disorder was initially thought to carry a 
relatively benign course, it is estimated that 1% to 2% of 
all patients with IgAN will develop end-stage renal disease 
(ESRD) each year from the time of diagnosis2. The incidence 
of ESRD is 10 percent at 5 years, and this percentage 
increases to 15, 20 and 30 percent at 10, 15 and 20 years 
of diagnosis respectively3.
Identification of clinical and histological features that predict 
poor prognosis is important for patient therapy selection.
PATIENTS AND METHODS 
Patient identification 
Patients were identified from a database of renal biopsies 
performed in native kidney, in South Coimbra Health Region, 
Portugal. All patients had a biopsy demonstrating IgAN in 
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the 20-year period between 1990 and 2010. Henoch-Schönlein 
purpura was excluded, as were other systemic diseases 
associated with mesangial IgA deposition: systemic lupus 
erythematosus, liver cirrhosis, hepatitis, HIV disease.
A total of 63 patients with IgAN were identified from the 
renal biopsy database of 402 cases. Those with secondary 
causes of mesangial IgA deposits were excluded: alcoholic 
cirrhosis (N=3), Hepatitis B (N=3), Henoch-Schönlein purpura 
(N=2), systemic lupus erythematosus (N=1), HIV infection 
(N=1) and ulcerative colitis (N=1). Three patients had miss-
ing follow-up data and were excluded as they were assumed 
not to have reached the primary outcome.
Data from 49 cases were available for analysis with a 
median follow-up of 4 years and an interquartile range of 
1 to 10.8 years.
Histopathology 
IgAN in the native kidney is defined as dominant or 
co-dominant staining with IgA in glomeruli by immuno-
fluorescence or immunoperoxidase. The intensity of IgA 
staining should be more than trace and the distribution 
should include presence in the mesangium, with or without 
capillary loop staining, excluding a pure membranous, 
diffuse, global granular glomerular basement membrane 
(GBM) staining pattern or a linear GBM staining pattern. 
IgG and IgM may be present, but not in greater intensity 
than IgA, except that IgM may be prominent in sclerotic 
areas. Complement C3 may be present4.
All histopathologic samples were reviewed and scored 
by a single renal pathologist of the Renal Morphology 
Laboratory of the Curry Cabral Hospital, Lisbon, Portugal.
Pathology variables assessed were mesangial hypercel-
lularity, endocapillary hypercellularity, extracapillary lesions 
(cellular, fibrocellular and fibrous crescent), glomeruloscle-
rosis, adhesions, tubular atrophy, interstitial fibrosis, acute 
tubular injury and arteriolar hyalinosis.
Continuous parameters (e.g. interstitial fibrosis) were esti-
mated visually. A semi-quantitative histological scoring was 
used in glomerulosclerosis (segmental and/or global), tubular 
atrophy, interstitial fibrosis and arteriolar hyalinosis: classified 
as absent (0%), mild (1-24%), moderate (25-50%) or severe 
(>50%). Glomerulosclerosis and adhesions were summed for 
statistical power, as were interstitial fibrosis and tubular atro-
phy. The percentage of glomeruli showing mesangial 
hypercellularity was simplified to ≤50 or >50%. Endocapillary 
hypercellularity, extracapillary proliferation and acute tubular 
injury were categorised as either present or absent.
Clinical data 
Clinical characteristics were obtained from the patient’s 
nephrology clinic chart. Serum creatinine measurement and 
24-hour urine protein taken immediately before the renal 
biopsy were used as baseline values. Estimated glomerular 
filtration rate (eGFR) was calculated using the four-variable 
MDRD formula. An eGFR <60 mL/min/1.73 m2 for ≥3 months 
was considered low eGFR. Values of eGFR were distributed 
within stages of the Kidney Disease Outcomes Quality Ini-
tiative (KDOQI) classification of chronic kidney disease 
(CKD). Arterial hypertension was defined as blood pressure 
≥140/90 mmHg or antihypertensive medication prescription. 
Children were subjects aged <12 years at biopsy.
Treatment modalities at the time of renal biopsy and/or 
during follow-up were classified as angiotensin-converting 
enzyme inhibitor and/or angiotensin receptor blockers, fish 
oil, tonsillectomy and immunosuppressive agents.
Outcome data were obtained from the nephrologists’ 
follow-up consultations and/or hospital stay reports.
Primary outcomes were (1) renal survival: ≥50% reduc-
tion from baseline eGFR or end-stage renal disease (ESRD), 
defined as an eGFR <15 mL/min/1.73 m2, permanent hae-
modialysis, peritoneal dialysis or renal transplantation and 
(2) death from any cause.
Patients were stratified into group I or II if they did not 
reach or reached the primary outcome, respectively.
Secondary outcomes analysed were achievement of a 
complete or partial remission. Complete remission was 
defined as proteinuria <0.3 g/day, while a partial remission 
was defined as ≥50% reduction in protein excretion from 
the peak value (with proteinuria ≥0.3 g/day).
Statistical analysis 
Parametric variables were expressed as mean±standard 
deviation (SD) and were compared using Student’s t-test. 
Non-parametric variables were expressed as median and 
interquartile range (IQR) and compared using Mann-Whitney 
and Spearman tests. Categorical variables were expressed 
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in percentages and were compared using Chi-square test. 
Fisher’s exact test was used on a 2x2 table with ≥1 cells 
with an expected frequency ≤5. The prognostic significance 
of clinical and histopathologic parameters was determined 
using Kaplan-Meier survival analysis, univariate and mul-
tivariate Cox proportional hazards models. All p-values 
were two-tailed and values <0.05 were considered statisti-
cally significant. Confidence intervals included 95% of 
predicted values. Analyses were carried out using SPSS 
software (version 17; SPSS Inc. Chicago IL, USA).
RESULTS 
Population 
Baseline clinical features and treatment modalities at the 
time of renal biopsy are given in Table I. All patients were 
Caucasian and no children were included in the study.
At presentation, there were 16 (32.7%) patients with 
low eGFR, with one patient already on ESDR. Two patients 
presented acute renal failure (without gross haematuria) 
as the initial manifestation of IgAN; both went on to ESRD 
years later (median time 3.8 years). A third patient devel-
oped acute renal injury during an episode of gross hae-
maturia that required temporary dialysis; the renal biopsy 
revealed acute tubular necrosis and there was complete 
recovery of renal function thereafter.
Renin-angiotensin system blockade (RAS) consisted of 
angiotensin-converting enzyme inhibitor and/or angiotensin 
receptor blocker. Fish oil was used in combination with 
RAS blockade in 4.3% patients. Patients with synpharyngitic 
haematuria following recurrent tonsillitis went on to a 
consultation with an otolaryngologist, and 10.4% of these 
underwent tonsillectomy. Glucocorticoids were the only 
immunosuppressive medication used; two patients with 
persistent proteinuria >1 g/day (despite optimised RAS 
blockade and fish oil therapy) without low eGFR and a 
third patient, an adolescent with acute onset nephrotic 
syndrome and severe azotaemia.
Primary Outcome 
Ten patients (20.4%) developed ESRD, none presented 
with a ≥50% reduction from baseline eGFR or died. The 
actuarial renal survival from the time of renal biopsy was 
76% at five-years.
Univariable model 
• Clinical characteristics and treatment modalities
 Baseline clinical characteristics of groups I and II and 
treatment modalities at time of biopsy and/or during 
follow-up are shown in Table II. About 50% of patients 
in group II had proteinuria ≥1 g/L, 30% of them in 
the nephrotic range.
Table I




Age (years; mean ± SD) 35.8 ± 13
Male (%) 65.4











Low eGFR (%) 32.7
Arterial hypertension (%) 55.6


















Age (years; mean ± SD) 35.5 ± 13 37 ± 16 NS
Male (%) 64 70 NS
























Low eGFR (%) 20.5 80 < 0.001
Arterial hypertension (%) 45.7 90 0.013
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• Histopathologic features
 The renal biopsies of group II had significantly more 
glomerulosclerosis/adhesions >50%, interstitial fibrosis/
tubular atrophy and endocapillary hypercellularity 
(Table III). A correlation between glomerulosclerosis/
adhesions and interstitial fibrosis/tubular atrophy 
(p<0.001, r2=0.508) was observed.
 There was a significant association by univariate 
analysis between proteinuria at time of biopsy and 
glomerulosclerosis/adhesions (p=0.044).
 Univariate survivorship analysis identified acute renal 
failure (p=0.019), low eGFR (p<0.001), arterial hyper-
tension (p=0.007), baseline proteinuria (HR 1, 95% 
CI 1-1, p=0.009), glomerulosclerosis/adhesions >50% 
(p=0.001) and tubular atrophy/interstitial fibrosis 
>50% (p<0.001) as poor prognostic markers.
Multivariable model 
• Clinical characteristics
 The multivariable model with clinical predictor vari-
ables significant by univariate survival analysis (acute 
renal failure, low eGFR, arterial hypertension and base-
line proteinuria) revealed that patients with low eGFR 
were at higher risk of progressing to ESRD (Fig. 1).
• Histopathologic features
 The multivariable model with significantly histopatho-
logical parameters by univariate survival analysis 
(glomerulosclerosis/adhesions >50% and tubular atrophy/
interstitial fibrosis >50%) observed that tubular 









Glomerulosclerosis/adhesions > 50% (%) 7.7 44.4 0.005
























Mesangial hypercellularity > 50% (%) 33.3 22.2 NS
Endocapillary hypercellularity (%) 0 11.1 0.043
Extracapillary lesions (%) 11.1 11.1 NS
Acute tubular injury (%) 2.8 0 NS 
Figure 1
Renal survival plot for Cox regression in a multivariate model adjusted for clinical param-
eters (acute renal failure, low eGFR, arterial hypertension and baseline proteinuria)
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atrophy/interstitial fibrosis >50% was independently 
associated with the primary outcome (Fig. 2).
• Clinical and histopathologic features
 The full model including both clinical and histopatho-
logic parameters had no statistical power.
Secondary outcomes 
Proteinuria throughout follow-up did not differ between 
groups (Fig. 3). Complete and partial remission occurred 
in 28.2% and 33.3% of patients in group I respectively, 
versus 25% and 37.5% patients in group II.
Prognostic factors in adult patients with idiopathic IgA Nephropathy
Figure 3
Boxplot of follow-up proteinuria (each box shows the median, IQR and extreme values 
within groups) 
Figure 2
Renal survival plot for Cox regression in a multivariate model adjusted for histopathological 
parameters (glomerulosclerosis/adhesions >50% and tubular atrophy/interstitial fibrosis >50%)
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DISCUSSION 
IgAN is the most common form of primary glomerulo-
nephritis in developed countries5-7. Variations in disease 
prevalence may in large part reflect regional differences 
in screening for kidney disease and kidney biopsy prac-
tices7,8. The outcome is extremely variable and difficult to 
predict3. Untreated adult patients with idiopathic IgAN 
have an actuarial 10-year renal survival rate ranging from 
80% to 85%5.
Accurately predicting which individuals will go on to 
develop progressive disease would allow physicians to 
target high-risk patients for aggressive treatment or moni-
toring. The possibility of early intervention is of consider-
able interest because there is speculation that there may 
be a point of no return in CKD5,9 beyond which interven-
tions are unlikely to affect prognosis significantly.
Independent clinical risk factors linked to progressive 
IgAN include impaired renal function at presentation, arte-
rial hypertension and proteinuria (especially proteinuria 
>1g/24 h) at presentation and during follow-up2,10-17.
Acute renal failure related with macroscopic haematuria 
is most likely associated with heavy glomerular haematuria 
leading to tubular occlusion and/or damage by red cells 
and not to crescentic IgAN18-20. After an episode of gross 
haematuria, renal function typically returns to baseline 
and the long-term prognosis is good18. It is important to 
note that acute renal failure may also occur as the initial 
presentation of a previously undetected CKD.
Male gender, older age at presentation, persistent micro-
scopic haematuria and absence of any history of recurrent 
macroscopic haematuria lose their prognostic value by 
multivariate analysis in the majority of studies5.
Our study supports the value of impaired renal function 
(acute renal failure and low eGFR), arterial hypertension 
and baseline proteinuria as poor prognostic markers in 
univariate analysis; low eGFR persisted as predictor of an 
unfavorable outcome by multivariable model. Data reported 
to nephrotic syndrome at presentation, magnitude of pro-
teinuria at presentation and during follow-up were not 
statistically significant.
Findings on renal biopsy have been associated with an 
increased risk of progressive disease. In multivariate analy-
ses, the extent of glomerulosclerosis and tubulointerstitial 
disease are most commonly associated with a poor 
prognosis4,5,21. These indicators are typical of most glom-
erular diseases4,5,21.
The Oxford classification system of IgAN4,21 suggests 
that four histopathologic features correlate with renal out-
comes: mesangial cellularity; segmental glomerular scle-
rosis; endocapillary hypercellularity; percentage of inter-
stitial fibrosis/tubular atrophy.
Our review supports the importance of glomerular scle-
rosis and interstitial fibrosis as significant predictors of 
outcome by univariate analysis but mesangial cellularity 
and endocapillary hypercellularity were not significant pre-
dictors. Our study also supports the reproducibility of 
quantitative reporting and the significance of glomerular 
sclerosis >50% and tubular atrophy/interstitial fibrosis 
>50% in univariate analysis. Tubulointerstitial damage 
remained significant by multivariate analysis. The prog-
nostic utility of crescents, necrotising lesions and extent 
of arteriolar hyaline was null in our study.
Our results differ from those of The Oxford classification 
system of IgAN21. Discrepancy may be due to the use of 
different outcomes (ESRD versus slope of renal function, 
≥50% decline of eGFR or ESRD), case mix (median follow-
up was inferior; our patients were older and no children 
were incorporated; all individuals were Caucasian; there 
were fewer men; CKD stage 1 was more prevalent and our 
study did not discard patients with CKD stage 4 and 5; 
arterial hypertension was more prevalent and median pro-
teinuria at biopsy was lower) and/or sample size (49 versus 
265 cases).
Our study fully endorses the value of clinical features 
and histopathologic parameters in IgAN prognosis. The 
results should be interpreted within the context of the 
study’s limitations. Continuous histopathologic parameters 
were estimated visually and were not re-read by the study’s 
renal pathologist to test intra-rater consistency, nor 
reviewed by a second renal pathologist to assess inter-
rater reliability. As in all observational studies, the pos-
sibility of residual confounding or misclassification of 
outcomes cannot be excluded.
We demonstrated in a single-centre retrospective 
cohort of IgAN that three clinical features at time of 
biopsy were strong indicators of unfavorable prognosis 
by univariate analysis: impaired renal function (acute 
renal failure and low eGFR), arterial hypertension and 
baseline proteinuria. Low eGFR persisted significant by 
multivariable model.
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Estimates of two simple histopathologic parameters – 
interstitial fibrosis/tubular atrophy >50% and glomerulo-
sclerosis/adhesions >50% were associated with a greater 
risk for ESRD. Severe tubulointerstitial damage remained 
significant by multivariate analysis.
Conflict of interest statement. None declared.
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